Terakawa N - Search Results

1

Outcome of patients with early ovarian cancer undergoing three courses of adjuvant chemotherapy following complete surgical staging.

Shimada M, Kigawa J, Kanamori Y, Itamochi H, Oishi T, Minagawa Y, Ishihara K, Takeuchi Y, Okada M, Terakawa N. Shimada M, et al. Among authors: terakawa n. Int J Gynecol Cancer. 2005 Jul-Aug;15(4):601-5. doi: 10.1111/j.1525-1438.2005.00115.x. Int J Gynecol Cancer. 2005. PMID: 16014112 Free article. Clinical Trial.

2

The outcome of radiation therapy in elderly patients with advanced cervical cancer.

Minagawa Y, Kigawa J, Itamochi H, Terakawa N. Minagawa Y, et al. Among authors: terakawa n. Int J Gynaecol Obstet. 1997 Sep;58(3):305-9. doi: 10.1016/s0020-7292(97)00124-0. Int J Gynaecol Obstet. 1997. PMID: 9286865

3

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.

Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N. Kigawa J, et al. Among authors: terakawa n. Cancer. 1998 Feb 15;82(4):697-702. doi: 10.1002/(sici)1097-0142(19980215)82:4<697::aid-cncr12>3.0.co;2-t. Cancer. 1998. PMID: 9477102

4

Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer.

Kigawa J, Minagawa Y, Cheng X, Terakawa N. Kigawa J, et al. Among authors: terakawa n. Clin Cancer Res. 1998 Jul;4(7):1737-41. Clin Cancer Res. 1998. PMID: 9676849

5

Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.

Okada M, Kigawa J, Minagawa Y, Kanamori Y, Shimada M, Takahashi M, Oishi T, Terakawa N. Okada M, et al. Among authors: terakawa n. Gynecol Oncol. 1998 Jul;70(1):61-4. doi: 10.1006/gyno.1998.5005. Gynecol Oncol. 1998. PMID: 9698475 Clinical Trial.

6

Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer.

Minagawa Y, Kigawa J, Irie T, Okada M, Kanamori Y, Terakawa N. Minagawa Y, et al. Among authors: terakawa n. Ann Surg Oncol. 1998 Sep;5(6):539-43. doi: 10.1007/BF02303647. Ann Surg Oncol. 1998. PMID: 9754763 Clinical Trial.

7

Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer.

Kigawa J, Takahashi M, Minagawa Y, Oishi T, Sugiyama T, Yakushiji M, Terakawa N. Kigawa J, et al. Among authors: terakawa n. Int J Cancer. 1999 Oct 22;84(5):521-4. doi: 10.1002/(sici)1097-0215(19991022)84:5<521::aid-ijc13>3.0.co;2-x. Int J Cancer. 1999. PMID: 10502731

8

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma.

Sato S, Kigawa J, Minagawa Y, Okada M, Shimada M, Takahashi M, Kamazawa S, Terakawa N. Sato S, et al. Among authors: terakawa n. Cancer. 1999 Oct 1;86(7):1307-13. Cancer. 1999. PMID: 10506718

9

Significance of cytoreductive surgery including bowel resection for patients with advanced ovarian cancer.

Shimada M, Kigawa J, Minagawa Y, Irie T, Takahashi M, Terakawa N. Shimada M, et al. Among authors: terakawa n. Am J Clin Oncol. 1999 Oct;22(5):481-4. doi: 10.1097/00000421-199910000-00012. Am J Clin Oncol. 1999. PMID: 10521063

10

Alteration of telomerase activity in ovarian cancer after chemotherapy.

Takahashi M, Kigawa J, Oishi T, Itamochi H, Shimada M, Sato S, Kamazawa S, Akeshima R, Terakawa N. Takahashi M, et al. Among authors: terakawa n. Gynecol Obstet Invest. 2000;49(3):204-8. doi: 10.1159/000010247. Gynecol Obstet Invest. 2000. PMID: 10729763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters